Organovo Holdings, Inc. (ONVO) NASDAQ

2.04

+0.03(+1.49%)

Updated at April 23, 2025 04:00PM

Currency In USD

Organovo Holdings, Inc.

Address

11555 Sorrento Valley Road

Solana Beach, CA 92121

United States of America (the)

Phone

858 224 1000

Sector

Healthcare

Industry

Biotechnology

Employees

14

First IPO Date

February 14, 2012

Key Executives

NameTitlePayYear Born
Vaidehi JoshiDirector of Discovery Biology & Director91,8001986
Keith E. MurphyExecutive Chairman & Corporate Secretary762,7361972
Curtis TyreeSenior Vice President of Strategy & Business Development0N/A
Norman StaskeyPresident, Chief Financial Officer & Principal Financial Officer01970

Description

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.